Artelo Biosciences Analyst Ratings
Artelo Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 316.67% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 04/03/2023 | 4900% | Ladenburg Thalmann | → $60 | Reiterates | → Buy |
| 02/03/2023 | 4483.33% | HC Wainwright & Co. | → $55 | Reiterates | → Buy |
| 08/12/2022 | 4483.33% | HC Wainwright & Co. | → $55 | Maintains | Buy |
| 11/01/2021 | 233.33% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
| 02/12/2021 | 483.33% | Ladenburg Thalmann | → $7 | Initiates Coverage On | → Buy |
| 01/07/2021 | — | Maxim Group | Upgrades | Hold → Buy | |
| 05/13/2020 | — | Maxim Group | Downgrades | Buy → Hold | |
| 07/09/2019 | 566.67% | Maxim Group | → $8 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/14/2023 | 316.67% | HC Wainwright & Co. | → 5 美元 | 重申 | 購買 → 購買 |
| 04/03/2023 | 4900% | 拉登堡塔爾曼 | → 60 美元 | 重申 | → 購買 |
| 02/03/2023 | 4483.33% | HC Wainwright & Co. | → 55 美元 | 重申 | → 購買 |
| 2022 年 12 月 8 日 | 4483.33% | HC Wainwright & Co. | → 55 美元 | 維護 | 買 |
| 11/01/2021 | 233.33% | HC Wainwright & Co. | → 4 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 02/12/2021 | 483.33% | 拉登堡塔爾曼 | → 7 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 01/07/2021 | — | Maxim 集團 | 升級 | 持有 → 買入 | |
| 05/13/2020 | — | Maxim 集團 | 降級 | 買入 → 持有 | |
| 07/09/2019 | 566.67% | Maxim 集團 | → 8 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Artelo Biosciences (ARTL)?
Artelo Biosciences（ARTL）的目標價格是多少？
The latest price target for Artelo Biosciences (NASDAQ: ARTL) was reported by HC Wainwright & Co. on November 14, 2023. The analyst firm set a price target for $5.00 expecting ARTL to rise to within 12 months (a possible 316.67% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月14日公佈了Artelo Biosciences（納斯達克股票代碼：ARTL）的最新目標股價。該分析公司將目標股價定爲5.00美元，預計ARTL將在12個月內升至12個月內（可能上漲316.67％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Artelo Biosciences (ARTL)?
分析師對Artelo Biosciences（ARTL）的最新評級是多少？
The latest analyst rating for Artelo Biosciences (NASDAQ: ARTL) was provided by HC Wainwright & Co., and Artelo Biosciences reiterated their buy rating.
HC Wainwright & Co. 提供了Artelo Biosciences（納斯達克股票代碼：ARTL）的最新分析師評級，Artelo Biosciences重申了買入評級。
When is the next analyst rating going to be posted or updated for Artelo Biosciences (ARTL)?
Artelo Biosciences（ARTL）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Artelo Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Artelo Biosciences was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Artelo Biosciences的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Artelo Biosciences的最新評級是在2023年11月14日發佈的，因此您應該預計下一個評級將在2024年11月14日左右公佈。
Is the Analyst Rating Artelo Biosciences (ARTL) correct?
分析師對Artelo Biosciences（ARTL）的評級是否正確？
While ratings are subjective and will change, the latest Artelo Biosciences (ARTL) rating was a reiterated with a price target of $0.00 to $5.00. The current price Artelo Biosciences (ARTL) is trading at is $1.20, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Artelo Biosciences（ARTL）評級得到了重申，目標股價爲0.00美元至5.00美元。Artelo Biosciences（ARTL）目前的交易價格爲1.20美元，在分析師的預測區間內。